Literature DB >> 28756714

Deciphering the MHC-associated peptidome: a review of naturally processed ligand data.

Kerrie Vaughan1, Xiaojun Xu1, Etienne Caron2, Bjoern Peters1, Alessandro Sette1.   

Abstract

INTRODUCTION: The availability of big data sets ('OMICS') has greatly impacted fundamental and translational science. High-throughput analysis of HLA class I and II associated peptidomes by mass spectrometry (MS) has generated large datasets, with the last decade witnessing tremendous growth in the breadth and number of studies. Areas covered: For this, we first analyzed naturally processed peptide (NP) data captured within the IEDB to survey and characterize the current state of NP data. We next asked to what extent the NP data overlap with existing T cell epitope and MHC binding data. Expert commentary: The current collection of NP data represents a large and diverse set of class I/II peptides mostly derived from self-antigens. These data overlap only marginally with existing immunogenicity and binding data and it is thus difficult to ascertain the correspondence between the different assay methodologies. This highlights a need for unbiased studies benchmarking in model antigen systems how well MHC binding and NP data predicts immunogenicity. Going forward, efforts at generating an integrated process for capturing all NP, curating associated metadata and accessing NP data from an immunological viewpoint will be important for development of novel methods for identifying optimal target antigens and for class I and II epitope prediction.

Keywords:  Epitopes; HLA; MHC; T cell; ligand; ligandome; mass spectrometry; naturally-processed; peptidome

Mesh:

Substances:

Year:  2017        PMID: 28756714     DOI: 10.1080/14789450.2017.1361825

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  15 in total

1.  Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.

Authors:  Sinu Paul; Edita Karosiene; Sandeep Kumar Dhanda; Vanessa Jurtz; Lindy Edwards; Morten Nielsen; Alessandro Sette; Bjoern Peters
Journal:  Front Immunol       Date:  2018-08-06       Impact factor: 7.561

Review 2.  The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction.

Authors:  Amanda L Creech; Ying S Ting; Scott P Goulding; John F K Sauld; Dominik Barthelme; Michael S Rooney; Terri A Addona; Jennifer G Abelin
Journal:  Proteomics       Date:  2018-02-23       Impact factor: 3.984

Review 3.  Predicting Antigen Presentation-What Could We Learn From a Million Peptides?

Authors:  David Gfeller; Michal Bassani-Sternberg
Journal:  Front Immunol       Date:  2018-07-25       Impact factor: 7.561

4.  Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction.

Authors:  Mareike Wendorff; Heli M Garcia Alvarez; Thomas Østerbye; Hesham ElAbd; Elisa Rosati; Frauke Degenhardt; Søren Buus; Andre Franke; Morten Nielsen
Journal:  Front Immunol       Date:  2020-08-05       Impact factor: 7.561

5.  ImmunomeBrowser: a tool to aggregate and visualize complex and heterogeneous epitopes in reference proteins.

Authors:  Sandeep Kumar Dhanda; Randi Vita; Brendan Ha; Alba Grifoni; Bjoern Peters; Alessandro Sette
Journal:  Bioinformatics       Date:  2018-11-15       Impact factor: 6.937

Review 6.  Systems vaccinology and big data in the vaccine development chain.

Authors:  René H M Raeven; Elly van Riet; Hugo D Meiring; Bernard Metz; Gideon F A Kersten
Journal:  Immunology       Date:  2018-11-13       Impact factor: 7.397

Review 7.  Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics.

Authors:  Jasmine Davda; Paul Declerck; Siwen Hu-Lieskovan; Timothy P Hickling; Ira A Jacobs; Jeffrey Chou; Shahram Salek-Ardakani; Eugenia Kraynov
Journal:  J Immunother Cancer       Date:  2019-04-15       Impact factor: 13.751

Review 8.  The Immune Epitope Database and Analysis Resource Program 2003-2018: reflections and outlook.

Authors:  Sheridan Martini; Morten Nielsen; Bjoern Peters; Alessandro Sette
Journal:  Immunogenetics       Date:  2019-11-25       Impact factor: 2.846

9.  HLA-dependent heterogeneity and macrophage immunoproteasome activation during lung COVID-19 disease.

Authors:  Christophe Desterke; Ali G Turhan; Annelise Bennaceur-Griscelli; Frank Griscelli
Journal:  J Transl Med       Date:  2021-07-05       Impact factor: 5.531

10.  A Targeted LC-MS Strategy for Low-Abundant HLA Class-I-Presented Peptide Detection Identifies Novel Human Papillomavirus T-Cell Epitopes.

Authors:  Renata Blatnik; Nitya Mohan; Maria Bonsack; Lasse G Falkenby; Stephanie Hoppe; Kathrin Josef; Alina Steinbach; Sara Becker; Wiebke M Nadler; Marijana Rucevic; Martin R Larsen; Mogjiborahman Salek; Angelika B Riemer
Journal:  Proteomics       Date:  2018-05-02       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.